$2.44
-0.17-6.7%
Últ. Act.: Nov 5, 4:51 PM
Rocket Pharmaceuticals (RCKT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.34 | $-0.44 | $-0.42 | $-0.50 |
| Actual | $-0.37 | $-0.42 | $-0.38 | $-0.45 |
| Surprise | -208.8% | +4.55% | +9.52% | +10.0% |
| Revenue | ||||
| Estimate | $13.3M | — | $277780 | $250000 |
| Actual | $0 | $0 | — | $0 |
| Surprise | -100.0% | — | -100.0% | -100.0% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.40 | $-0.41 | $-0.25 | $-0.25 |
| Revenue | ||||
| Consensus | $445456 | $1.1M | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $-0.37 | $0.34 | -208.8 % |
| Q1 | May 7, 2026 | $-0.42 | $-0.44 | 4.55 % |
| Q4 | Feb 26, 2026 | $-0.38 | $-0.42 | 9.52 % |
| Q3 | Nov 6, 2025 | $-0.45 | $-0.50 | 10.0 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $0 | $13.34M | -100.0 % |
| Q4 | Feb 26, 2026 | $0 | $277.78K | -100.0 % |
| Q3 | Nov 6, 2025 | $0 | $250.00K | -100.0 % |
| Q2 | Aug 7, 2025 | $0 | $4.36M | -100.0 % |